Exenatide

7 trials 3 recruiting AGastroenterology Orphan designation

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

3 Recruiting

1 Completed trials

5 Sponsors

11 Countries

Phase II

Phase I/II

Phase IV

Phase II: 5 Phase I/II: 1 Phase IV: 1

Sponsors using this IMP

Radboud universitair medisch centrum Stichting 3 Eli Lilly & Co. 1 Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau 1 Genesis Pharma S.A. 1 Region Stockholm – SLSO 1

All trials

7 total

An Open-label Phase 2b Study with Blinded Evaluation of the Combination of Amodiaquine and Potassium Canrenoate with Exenatide or Glibenclam… Not authorised

2025-522796-28-00 Phase II 1 country Genesis Pharma S.A.
Image-Verapamil SR in Adults with Type 1 Diabetes (Image-VER-A-T1D) Pending

2024-518554-17-00 Phase II 2 countries Radboud universitair medisch centrum Stichting
Imaging beta cells after gestational diabetes Pending

2024-520392-27-00 Phase II 1 country Radboud universitair medisch centrum Stichting
A Study of Tirzepatide Compared with Intensified Conventional Care in Adult Participants with Type 2 Diabetes (SURPASS-EARLY) Recruiting

2022-501073-40-00 Phase IV 5 countries Eli Lilly & Co.
Testing Exendin PET, a new imaging technique, for imaging paragangliomas Recruiting

2024-516755-40-00 Phase II 1 country Stichting Radboud universitair medisch centrum
Effect of Exenatide on disease progression in early Parkinson’s disease. Recruiting

2024-520069-30-00 Phase II 1 country Region Stockholm – SLSO
Identification and clinical relevance of an oxytocin-deficient state: randomized, crossover, placebo-controlled pilot physiopathological stu… Ended

2024-515588-67-00 Phase I/II 1 country Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau

Showing 1–7 of 7 trials

← All drugs A–Z